newsfilter
← Latest News
GlobeNewswire·

Tricida Announces Updates on Veverimer Development Program, Regulatory Status and New Patent Extending Protection through 2038

SOUTH SAN FRANCISCO, Calif., Dec. 08, 2020 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its investigational drug...